Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (manokatra rohy)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Loharanon-kevitra‎: Ann Intern Med 2008;148(12):939-55.

Rakitra‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (manokatra rohy)

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (manokatra rohy)

Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK.

Loharanon-kevitra‎: Am J Hematol 2000;64(1):26-31.

Rakitra‎: PubMed 10815784

https://www.ncbi.nlm.nih.gov/pubmed/10815784 (manokatra rohy)

Hydroxyurea for the treatment of sickle cell anemia. (manokatra rohy)

Platt OS.

Loharanon-kevitra‎: N Engl J Med 2008;358(13):1362-9.

Rakitra‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (manokatra rohy)

Clinical effectiveness of decitabine in severe sickle cell disease. (manokatra rohy)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Loharanon-kevitra‎: Br J Haematol 2008;141(1):126-9.

Rakitra‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (manokatra rohy)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (manokatra rohy)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Loharanon-kevitra‎: Blood 2010;115(12):2354-63.

Rakitra‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (manokatra rohy)

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (manokatra rohy)

Hirst C, Owusu-Ofori S.

Loharanon-kevitra‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Rakitra‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (manokatra rohy)

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (manokatra rohy)

Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E

Loharanon-kevitra‎: Lancet Haematol 2021;8(5):e323-33.

Rakitra‎: PubMed 33838113

DOI‎: 10.1016/S2352-3026(21)00059-4

https://www.ncbi.nlm.nih.gov/pubmed/33838113 (manokatra rohy)

Sickle cell disease. (manokatra rohy)

Meremikwu MM, Okomo U.

Loharanon-kevitra‎: BMJ Clin Evid 2011;02:2402.

Rakitra‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (manokatra rohy)

A phase 3 trial of l-glutamine in sickle cell disease. (manokatra rohy)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Loharanon-kevitra‎: N Engl J Med 2018;379(3):226-35.

Rakitra‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (manokatra rohy)

Malaria chemoprophylaxis in sickle cell disease. (manokatra rohy)

Oniyangi O, Omari AA.

Loharanon-kevitra‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Rakitra‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (manokatra rohy)